2010
Promoting Social Skill Development in Children With Pervasive Developmental Disorders: A Feasibility and Efficacy Study
Koenig K, White SW, Pachler M, Lau M, Lewis M, Klin A, Scahill L. Promoting Social Skill Development in Children With Pervasive Developmental Disorders: A Feasibility and Efficacy Study. Journal Of Autism And Developmental Disorders 2010, 40: 1209-1218. PMID: 20204689, DOI: 10.1007/s10803-010-0979-x.Peer-Reviewed Original ResearchConceptsOutcome measuresPervasive developmental disorderSecondary outcome measuresPrimary outcome measureDevelopmental disordersEfficacy studiesSkills interventionSocial skills interventionsGroup interventionGroup comparisonsParent questionnaireInterventionAge 8ChildrenPreliminary evidenceTreatmentDisordersSocial skills developmentAppropriate social behaviorHigh levelsHighlight challenges
2009
Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial
Aman MG, Mcdougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, Stigler KA, Bearss K, Butter E, Swiezy NB, Sukhodolsky DD, Ramadan Y, Pozdol SL, Nikolov R, Lecavalier L, Kohn AE, Koenig K, Hollway JA, Korzekwa P, Gavaletz A, Mulick JA, Hall KL, Dziura J, Ritz L, Trollinger S, Yu S, Vitiello B, Wagner A, Network F. Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial. Journal Of The American Academy Of Child & Adolescent Psychiatry 2009, 48: 1143-1154. PMID: 19858761, PMCID: PMC3142923, DOI: 10.1097/chi.0b013e3181bfd669.Peer-Reviewed Original ResearchConceptsPervasive developmental disorderClinical trialsClinical Global Impressions-Improvement scoreAberrant Behavior Checklist IrritabilityParallel-group clinical trialParent trainingBehavioral problemsDevelopmental disordersRisperidone doseRisperidone monotherapyHyperactivity/noncompliance subscaleSevere behavioral problemsCOMB groupPT sessionsQuestionnaire scoresHSQ scoresMedicationsGreater reductionChildrenPrimary measureRisperidoneSignificant reductionStereotypic behaviorScoresDose